A Phase 1/2 Study of Weekly Carfilzomib in Combination With Dexamethasone for Progressive Multiple Myeloma
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 24 Jul 2018
At a glance
- Drugs Carfilzomib (Primary) ; Dexamethasone (Primary) ; Dexamethasone (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- Acronyms CHAMPION-1
- Sponsors Amgen; Onyx Pharmaceuticals
- 18 Jun 2018 Planned End Date changed from 30 Sep 2018 to 31 Dec 2018.
- 23 Apr 2018 Planned End Date changed from 30 Mar 2018 to 30 Sep 2018.
- 21 Dec 2017 Planned End Date changed from 31 Dec 2017 to 30 Mar 2018.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History